Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
-
Published:2018-09-27
Issue:10
Volume:50
Page:1399-1411
-
ISSN:1061-4036
-
Container-title:Nature Genetics
-
language:en
-
Short-container-title:Nat Genet
Author:
Lee Jin-KuORCID, Liu Zhaoqi, Sa Jason K., Shin Sang, Wang JiguangORCID, Bordyuh Mykola, Cho Hee Jin, Elliott Oliver, Chu Timothy, Choi Seung WonORCID, Rosenbloom Daniel I. S.ORCID, Lee In-HeeORCID, Shin Yong Jae, Kang Hyun Ju, Kim Donggeon, Kim Sun Young, Sim Moon-Hee, Kim Jusun, Lee Taehyang, Seo Yun Jee, Shin Hyemi, Lee Mijeong, Kim Sung Heon, Kwon Yong-Jun, Oh Jeong-Woo, Song Minsuk, Kim Misuk, Kong Doo-Sik, Choi Jung Won, Seol Ho Jun, Lee Jung-Il, Kim Seung Tae, Park Joon Oh, Kim Kyoung-Mee, Song Sang-Yong, Lee Jeong-Won, Kim Hee-Cheol, Lee Jeong Eon, Choi Min Gew, Seo Sung Wook, Shim Young Mog, Zo Jae Ill, Jeong Byong Chang, Yoon Yeup, Ryu Gyu Ha, Kim Nayoung K. D.ORCID, Bae Joon Seol, Park Woong-Yang, Lee Jeongwu, Verhaak Roel G. W.ORCID, Iavarone Antonio, Lee JeeyunORCID, Rabadan Raul, Nam Do-Hyun
Publisher
Springer Science and Business Media LLC
Reference155 articles.
1. Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462–477 (2013). 2. Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113–1120 (2013). 3. Hamburg, M. A. & Collins, F. S. The path to personalized medicine. N. Engl. J. Med. 363, 301–304 (2010). 4. Slamon, D. J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344, 783–792 (2001). 5. Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507–2516 (2011).
Cited by
143 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|